Evaluation for effect of SGLT2 inhibitor on postprandial hyperglycemia and cardiac function in diabetic patients with coronary artery disease
Not Applicable
- Conditions
- Coronary artery disease, Diabetes
- Registration Number
- JPRN-UMIN000031549
- Lead Sponsor
- Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
1.Patients who have already taken SGLT2 inhibitor 2.Patients with drug allergy of SGLT2 inhibitor 3.Patients with history of anteroseptal myocardial infarction 4.Patients had received hemodialysis 5.Creatinine Clearance < 30 ml/min 6.Patients with contraindication of MRI 7.Patients who judged as ineligible clinical staffs
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Changes of postprandial hyperglycemia after administration SGLT 2 inhibitor for 12 weeks
- Secondary Outcome Measures
Name Time Method Changes of cardiac function and myocardial triglyceride content after administration SGLT 2 inhibitor for 12 weeks